Drug profile · INN
norethindrone acetate
NORETHINDRONE ACETATE
norethindrone acetate (NORETHINDRONE ACETATE) is a progesterone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — norethindrone acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 5
- Programs
- 1
- Data quality
- 0.89
Quick answer
norethindrone acetate (NORETHINDRONE ACETATE) is a progesterone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11957684
Treatment of heavy menstrual bleeding associated with uterine fibroids
granted -
US 11793812
Methods of treating endometriosis
granted -
US 11033551
Methods of treating uterine fibroids
granted -
US 8058280
Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
granted -
US 7300935
Thienopyrimidine compounds and use thereof
granted
Frequently asked questions
What is norethindrone acetate?
norethindrone acetate (NORETHINDRONE ACETATE) is a progesterone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for norethindrone acetate?
NORETHINDRONE ACETATE is a marketed brand name for norethindrone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of norethindrone acetate?
norethindrone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.